# Tolerability of ALK Tree Tablet

> **NCT00535639** · PHASE1 · COMPLETED · sponsor: **ALK-Abelló A/S**

## Conditions studied

- Allergy

## Interventions

- **DRUG:** Betula Verrucosa allergen extract

## Key facts

- **NCT ID:** NCT00535639
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2007-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00535639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00535639, "Tolerability of ALK Tree Tablet". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00535639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*